Literature DB >> 14621276

Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life.

F Pace1, P Molteni, S Bollani, P Sarzi-Puttini, R Stockbrügger, G Bianchi Porro, D A Drossman.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are intestinal diseases perceived differently by patients and doctors: the former is considered essentially as an 'organic' disease (i.e. an illness in which the role of stress or psychological factors is at best secondary to the disease itself), whereas the latter is acknowledged as a 'functional' disorder (i.e. illness thought to be more in the 'mind' than in the body of the patient). Accordingly, the respective impact of the two diseases on patients' health-related quality of life (HRQOL) is perceived to be very different. We aimed to compare the relative impact of the disease on HRQOL, psychological profile and perceived burden of stressful life events in two groups of outpatients suffering from IBS and IBD and attending our outpatient department at an Italian university hospital. Eighty patients with IBD (26 with ulcerative colitis and 54 with Crohn disease) and 85 controls with IBS formed the patient samples of the study.
METHODS: Three questionnaires were given to the patients while they were attending the outpatient department because of their previously diagnosed disease, namely the SF-36 (a generic well-validated tool for measuring HRQOL), the SCL-90 (for assessing the psychological profile of patients), and the Holmes & Rahe schedule (for the assessment of stressful life experiences). The results were then compared by means of analysis of variance (ANOVA) and Bonferroni-adjusted t test, when appropriate.
RESULTS: HRQOL appeared to be similarly reduced in both disease groups (SF-36 overall mean value: 58.2 +/- 16.1 in IBS patients versus 56.4 +/- 22.3 in IBD patients: P > 0.05) in comparison with normative Italian data. Furthermore, the overall severity of psychological symptoms was not statistically different between patients suffering from IBD versus IBS, as shown by SCL-90 mean scores of 0.89 + 0.45 versus 0.83 +/- 0.48, respectively (P > 0.05). On the contrary, the severity of recent stressful life experiences was perceived to be higher by IBS than by IBD patients (mean SRE score: 110.8 = 110.2 versus 61.6 +/- 78.8; P < 0.05).
CONCLUSION: Our study supports the notion that, at least in referral centres, patients with IBS show health-related quality of life, psychological distress and recent occurrence of stressful life events of severity at least comparable with age-matched IBD patients.

Entities:  

Mesh:

Year:  2003        PMID: 14621276     DOI: 10.1080/00365520310004524

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  29 in total

1.  Acute nociceptive somatic stimulus sensitizes neurones in the spinal cord to colonic distension in the rat.

Authors:  Shachar Peles; Adrian Miranda; Reza Shaker; Jyoti N Sengupta
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

2.  A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey.

Authors:  Linda Y L Tang; Alice Nabalamba; Leslie A Graff; Charles N Bernstein
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

3.  Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease.

Authors:  Garth R Swanson; Shahriar Sedghi; Ashkan Farhadi; Ali Keshavarzian
Journal:  Alcohol       Date:  2010-05       Impact factor: 2.405

4.  Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis.

Authors:  Bruce D Naliboff; Sharon E Kim; Roger Bolus; Charles N Bernstein; Emeran A Mayer; Lin Chang
Journal:  Am J Gastroenterol       Date:  2011-11-15       Impact factor: 10.864

5.  Perceptions of illness stigma in patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  Tiffany H Taft; Laurie Keefer; Caroline Artz; Jason Bratten; Michael P Jones
Journal:  Qual Life Res       Date:  2011-03-20       Impact factor: 4.147

6.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 7.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Constructive thinking, rational intelligence and irritable bowel syndrome.

Authors:  Enrique Rey; Marta Moreno Ortega; Monica-Olga Garcia Alonso; Manuel Diaz-Rubio
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

9.  Experimental gastritis in mice enhances anxiety in a gender-related manner.

Authors:  E Painsipp; T Wultsch; A Shahbazian; M Edelsbrunner; M C Kreissl; A Schirbel; E Bock; M A Pabst; C K Thoeringer; H P Huber; P Holzer
Journal:  Neuroscience       Date:  2007-09-18       Impact factor: 3.590

Review 10.  Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?

Authors:  Anna Matheis; Ute Martens; Johannes Kruse; Paul Enck
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.